Market Overview:
The global insulin delivery pens market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, rising awareness about diabetes and its treatment, and technological advancements in insulin delivery pens. Based on type, the global insulin delivery pens market is segmented into reusable insulin pens and disposable insulin pens. The disposable insulin pen segment is expected to grow at a higher CAGR than the reusable pen segment during the forecast period from 2018 to 2030. This can be attributed to their ease of use and low cost as compared with reusable pens. Based on application, the global Insulin Delivery Pens Market is divided into four segments: hospital pharmacy, retail pharmacy, online sales, and diabetes clinics.
Product Definition:
Insulin Delivery Pens are devices used to inject insulin under the skin. They come in a variety of shapes and sizes, but all work in basically the same way. A small needle is inserted into the skin, and insulin is injected through the needle.
- Convenience - Insulin Delivery Pens can be carried with you wherever you go. This makes it easy to take your medication on time, even if you're out and about.
- Accuracy - Insulin Delivery Pens deliver a precise dose of insulin each time they're used. This helps ensure that your blood sugar levels stay within target range.
Reusable Insulin Pens:
Reusable insulin pens are devices used to deliver rapid-acting insulin through injection sites. They are most commonly used by people who cannot use needles or other forms of artificial injectable due to religious reasons, allergies, or any other medical reason. The device is a pen containing disposable cartridges containing fast-acting insulin and it works on the principle of absorption which is similar to that of a syringe.
Disposable Insulin Pens:
Disposable insulin pens are used by patients who require multiple daily injections and those who are prone to accidents while using conventional syringes. The product is available in different sizes, which can be customized as per the requirements of patients.
The product has been designed with patient safety in mind, thereby avoiding potential hazards that may arise from reusable devices.
Application Insights:
The hospital pharmacy segment dominated the global insulin delivery pens market in 2017. This is attributed to factors such as an increase in the prevalence of diabetes and a growing number of hospitals across the globe. Hospital pharmacies are expected to have a significant share owing to their ability to stock various medicines at one place, thereby reducing traveling time for patients and healthcare professionals.
Furthermore, these facilities offer around-the-clock services which help patients with emergencies or life-threatening conditions requiring immediate medical attention. The retail pharmacy segment is expected to witness lucrative growth over the forecast period due largely on increasing penetration of pen injectors among diabetic retinopathy patients that can be treated at home without going into clinics or hospitals for diagnosis and treatment purposes resulting in reduced usage of hospital beds thus driving demand for insulin delivery pens globally over the forecast period.
Regional Analysis:
North America dominated the global insulin delivery pens market in 2017. This can be attributed to the presence of a large number of manufacturers and suppliers, high patient awareness levels coupled with relatively higher healthcare expenditure levels in this region as compared to other regions. The Asia Pacific is expected to grow at the fastest CAGR during the forecast period due to rising diabetic population, increasing disposable income levels and improving healthcare infrastructure especially in developing countries such as India and China. Moreover, an increase in outsourcing activities by developed economies is also contributing towards market growth across this region. For instance, Novo Nordisk has partnered with Bajaj Electricals Ltd.
The Europe market was valued at USD X million in 2017 owing to growing demand from Germany which accounted for a major share followed by U.K.
Growth Factors:
- Increasing prevalence of diabetes: The number of people affected by diabetes is increasing at an alarming rate all over the world. This is primarily because of the changing lifestyle and dietary habits. As a result, there is an increased demand for insulin delivery pens, which can help in administering insulin doses accurately and conveniently.
- Technological advancements: The development of new technologies has led to the introduction of advanced insulin delivery pens that are easier to use and offer more flexibility in terms of dosage adjustments. This is likely to boost the popularity of these devices among diabetics in the coming years.
- Growing awareness about diabetes: There has been a significant increase in awareness about diabetes among people across all age groups in recent years. This has led to a rise in demand for effective treatment options, including insulin delivery pens.
Scope Of The Report
Report Attributes
Report Details
Report Title
Insulin Delivery Pens Market Research Report
By Type
Reusable Insulin Pens, Disposable Insulin Pens
By Application
Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics
By Companies
Novo Nordisk, Sanofi Diabetes, Medtronic, BD, Animas, Roche, Insulet, Bomtech, BioSampling, Cardiocomm Solutions, Novo Nordisk, Kavo, Megasan Medical, Nipro, Mika Medical, Rudolf Riester, Smiths Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
149
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Insulin Delivery Pens Market Report Segments:
The global Insulin Delivery Pens market is segmented on the basis of:
Types
Reusable Insulin Pens, Disposable Insulin Pens
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novo Nordisk
- Sanofi Diabetes
- Medtronic
- BD
- Animas
- Roche
- Insulet
- Bomtech
- BioSampling
- Cardiocomm Solutions
- Novo Nordisk
- Kavo
- Megasan Medical
- Nipro
- Mika Medical
- Rudolf Riester
- Smiths Medical
Highlights of The Insulin Delivery Pens Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Reusable Insulin Pens
- Disposable Insulin Pens
- By Application:
- Hospital Pharmacy
- Retail Pharmacy
- Online Sales
- Diabetes Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Insulin Delivery Pens Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Insulin Delivery Pens are a type of insulin pen that delivers insulin through an injection. They are designed to help people with diabetes manage their blood sugar levels more effectively.
Some of the key players operating in the insulin delivery pens market are Novo Nordisk, Sanofi Diabetes, Medtronic, BD, Animas, Roche, Insulet, Bomtech, BioSampling, Cardiocomm Solutions, Novo Nordisk, Kavo, Megasan Medical, Nipro, Mika Medical, Rudolf Riester, Smiths Medical.
The insulin delivery pens market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Insulin Delivery Pens Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Insulin Delivery Pens Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Insulin Delivery Pens Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Insulin Delivery Pens Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Insulin Delivery Pens Market Size & Forecast, 2020-2028
4.5.1 Insulin Delivery Pens Market Size and Y-o-Y Growth
4.5.2 Insulin Delivery Pens Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Reusable Insulin Pens
5.2.2 Disposable Insulin Pens
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacy
6.2.2 Retail Pharmacy
6.2.3 Online Sales
6.2.4 Diabetes Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Insulin Delivery Pens Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Insulin Delivery Pens Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Reusable Insulin Pens
9.6.2 Disposable Insulin Pens
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacy
9.10.2 Retail Pharmacy
9.10.3 Online Sales
9.10.4 Diabetes Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Reusable Insulin Pens
10.6.2 Disposable Insulin Pens
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacy
10.10.2 Retail Pharmacy
10.10.3 Online Sales
10.10.4 Diabetes Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Reusable Insulin Pens
11.6.2 Disposable Insulin Pens
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacy
11.10.2 Retail Pharmacy
11.10.3 Online Sales
11.10.4 Diabetes Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Reusable Insulin Pens
12.6.2 Disposable Insulin Pens
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacy
12.10.2 Retail Pharmacy
12.10.3 Online Sales
12.10.4 Diabetes Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Reusable Insulin Pens
13.6.2 Disposable Insulin Pens
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacy
13.10.2 Retail Pharmacy
13.10.3 Online Sales
13.10.4 Diabetes Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Insulin Delivery Pens Market: Competitive Dashboard
14.2 Global Insulin Delivery Pens Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novo Nordisk
14.3.2 Sanofi Diabetes
14.3.3 Medtronic
14.3.4 BD
14.3.5 Animas
14.3.6 Roche
14.3.7 Insulet
14.3.8 Bomtech
14.3.9 BioSampling
14.3.10 Cardiocomm Solutions
14.3.11 Novo Nordisk
14.3.12 Kavo
14.3.13 Megasan Medical
14.3.14 Nipro
14.3.15 Mika Medical
14.3.16 Rudolf Riester
14.3.17 Smiths Medical
